Repligen(US:RGEN) Globenewswire·2025-11-04 12:30Core Insights - Repligen Corporation, a leader in bioprocessing technology, will attend five upcoming investor conferences in November 2025 [1][4] Company Overview - Repligen Corporation is a global life sciences company focused on developing and commercializing innovative bioprocessing technologies that enhance the manufacturing of biological drugs [3] - The company serves biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide, with a focus on areas such as Filtration and Fluid Management, Chromatography, Process Analytics, and Proteins [3] - Repligen's headquarters is located in Waltham, Massachusetts, with manufacturing sites primarily in the U.S. and additional locations in Estonia, France, Germany, Ireland, the Netherlands, and Sweden [3] Upcoming Conferences - The UBS Global Healthcare Conference will take place from November 10 to 12 in Palm Beach Gardens, FL, featuring CFO Jason Garland in an analyst-led discussion on November 10 at 11:00 a.m. ET [4] - The Stifel Healthcare Conference is scheduled for November 11 to 13 in New York, with CEO Olivier Loeillot participating in an analyst-led discussion on November 11 at 10:00 a.m. ET [4] - The Wolfe Research Healthcare Conference will occur from November 17 to 19 in New York, where CFO Jason Garland will speak on November 18 at 12:40 p.m. ET [4] - The Jefferies Global Healthcare Conference is set for November 18 to 20 in London, UK, with CEO Olivier Loeillot participating in a discussion on November 18 at 8:30 a.m. ET [4] - The Stephens Annual Investment Conference will be held from November 18 to 20 in Nashville, featuring CFO Jason Garland in one-on-one meetings with investors on November 19 [4]